Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial
Recruiting
Investigated Diseases:
+2
Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma
Recruiting
Investigated Diseases:Investigated Drugs:
Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis
Recruiting
Investigated Diseases:Investigated Drugs:
Study of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)
Recruiting
Investigated Drugs:
powered by
